Enoxaparin sodium × Ticagrelor

Enoxaparin blocks factor Xa and ticagrelor blocks platelet aggregation, so two separate points of haemostasis are hit at once. The enoxaparin label asks for medical supervision and laboratory monitoring when it is combined with antiplatelets, anti-inflammatory doses of salicylates and NSAIDs, and it also names thrombolytics and other anticoagulants.

Extensive bruising at injection sites, gum and nose bleeding, black stools, pink urine, unexplained back or abdominal pain that may indicate internal bleeding. Progressive anaemia shows as fatigue and pallor.

The combination exists in hospital protocols for acute coronary syndrome, with defined doses, duration and monitoring. Outside that setting they are not stacked on personal initiative, still less with an NSAID on top. Monitor haemoglobin, platelets and renal function, since enoxaparin accumulates when filtration falls.